Adam S Grossman

President and CEO · ADMA Biologics

Adam S Grossman (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in ADMA Biologics, Inc. (ADMA). The largest single filing was $1.8M of ADMA (147,000 sh across 2 lots, as filed), executed Nov 5. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$2.6M

shares × price, as filed

Last traded

Nov 5

Filed Nov 5

Median ADV $38.1M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

ADMA

ADMA Biologics, Inc. ADMA · 0 buys · 14 sells 14 filings

Recent filings

ADMASALE ADMA Biologics, Inc. View filing → $1.8M
147,000 sh across 2 lots
Exec Nov 5
Filed Nov 5 · 9:05 PM ET ADMASALE ADMA Biologics, Inc. View filing → $227K
15,000 sh × $15.16
Exec Mar 16
Filed Mar 17 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $241K
15,000 sh × $16.08
Exec Feb 17
Filed Feb 17 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $416K
21,000 sh across 2 lots
Exec Dec 15 2025
Filed Dec 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $240K
15,000 sh × $16.00
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $240K
15,000 sh × $16.00
Exec Oct 24 2025
Filed Oct 24 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $242K
15,000 sh × $16.13
Exec Sep 15 2025
Filed Sep 16 2025 · 5:30 PM ET ADMASALE ADMA Biologics, Inc. View filing → $354K
21,000 sh across 2 lots
Exec Aug 15 2025
Filed Aug 15 2025 · 5:30 PM ET More filings →